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Abstract 
Plant genome editing has the potential to become another chapter in the intractable debate that has dogged 
agricultural biotechnology. In 2016, 107 Nobel Laureates accused Greenpeace of emotional and dogmatic 
campaigning against agricultural biotechnology and called for governments to defy such campaigning. 
The Laureates invoke the authority of science to argue that Greenpeace is putting lives at risk by opposing 
agricultural biotechnology and Golden Rice and is notable in framing Greenpeace as unethical and its 
views as marginal.  This paper examines environmental, food and farming NGOs’ social and ethical 
concerns about genome editing, situating these concerns in comparison to alternative ethical assessments 
provided by the Nuffield Council on Bioethics, a key actor in this policy debate. In doing so, we show 
that participant NGOs and the Nuffield Council on Bioethics share considerable concerns about the social 
and ethical implications of genome editing. These concerns include choices over problem/solution 
framing and broader terminology, implications of regulatory and research choices on consumer choice 
and relations of power. However, GM-engaged NGOs and the Nuffield Council on Bioethics diverge on 
one important area: the NGOs seek to challenge the existing order and broaden the scope of debate to 
include deeply political questions regarding agricultural and technological choices. This distinction 
between the ethical positions means that NGOs provide valuable ethical insight and a useful lens to open 
up debate and discussion on the role of emerging technologies, such as genome editing, and the future of 
agriculture and food sovereignty.  
Keywords: agricultural biotechnology, plant genome editing; NGOs; ethics; Nuffield Council on 
Bioethics. 
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Introduction  
Plant genome editing has the potential to become another chapter in the intractable debate that has dogged 
agricultural biotechnology. In 2016, 107 Nobel Laureates accused Greenpeace of emotional and dogmatic 
campaigning against agricultural biotechnology and called for governments to defy such campaigning 
(Helliwell et al. 2017). The Laureates invoke the authority of science to argue that Greenpeace is putting 
lives at risk by opposing agricultural biotechnology and Golden Rice: “How many poor people in the 
world must die before we consider this a "crime against humanity"? (emphasis original, Support 
Precision Agriculture 2016). The Laureates also suggest that such opposition to genome editing is 
divorced from a reality in which agricultural biotechnology products are widely accepted as useful and 
their adoption is in the public interest. The Nobel Laureates’ letter is notable in framing Greenpeace as 
unethical and its views as marginal. In response, Greenpeace notes the International Rice Research 
Institute admits that Golden Rice has not been proven to address Vitamin A deficiency, describing Golden 
Rice as an overhyped, unwanted and costly failure. Instead, Greenpeace argue the solution to Vitamin A 
deficiency is diverse diet, equitable access to food and eco-agriculture (Greenpeace International 2016). 
The exchange highlighted both the polarisation between some scientists and non-governmental 
organisations (NGOs) engaged with genetic modification (GM) developments, such as Greenpeace and a 
lack of clarity about the social and ethical dimensions of agricultural biotechnology. 
In this article, we address these issues through an examination of the social and ethical issues raised by 
environmental, food and farming NGOs who have developed a position on agricultural biotechnology. In 
 
particular, we use the controversial case of plant genome editing to investigate relevant NGO positions on 
the social and ethical dimensions of agricultural biotechnology and test whether these positions are 
extreme or misaligned with current expert ethical assessment. The recent Nuffield Council on Bioethics 
(henceforth Nuffield) publication Genome editing: An ethical review (Nuffield Council on Bioethics 
2016) presents an opportunity to compare the positions of participant NGOs with a prominent ethical 
authority. This article presents focus group, interview and document analysis in order to compare 
environmental, food and farming NGOs and Nuffield framings of the social and ethical dimensions of 
plant genome editing. Our analysis shows four themes underlying NGO opposition to plant genome 
editing: 1. power and control; 2. terminology; 3. consumer choice; and, 4. problem/solution framings.  
Importantly, this paper shows that despite NGOs critical positions on GM developments being situated by 
pro-GM advocates as adopting an ethically and morally extreme position, the social and ethical concerns 
they raise are broadly akin to that of a mainstream ethical organisation such as Nuffield. The main 
exception to this being that the NGOs explicitly question what genome editing techniques mean for 
further increasing the scope of corporate power within agricultural systems. We argue it is the efforts of 
these NGOs to critically engage with questions of power surrounding which underlies the ‘scientised’ 
controversy over plant genome editing and is crucial for understanding the nature of the debate about 
genome editing and agricultural biotechnology more broadly. 
Background  
Plant genome editing 
Genome editing has generated significant interest and excitement from the scientific community (Doudna 
and Charpentier 2014; Ledford 2015; Komaroff 2017). Supporters of this new technology argue that plant 
genome editing will benefit agriculture promising improved efficiency, greater productivity and a broader 
range of varieties and that environmental applications could lead to novel approaches to biodiversity 
protection, conservation, bioremediation, and the control of invasive species (Shukla-Jones et al. 2018). In 
practice, most plant genome modification and commercial development is focused on herbicide tolerance, 
insect resistance, fungal resistance and drought tolerance traits (Jones 2015). This article focuses on three 
genome editing techniques from a broader suit of New Plant Breeding Techniques (NPBT): Zinc Finger 
Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs) and Clustered Regularly 
Interspersed Short Palindromic Repeats (CRISPR) (Nuffield Council on Bioethics 2016). ZFNs and 
TALENs are proteins that are customised to target and cut DNA at a specific site. CRISPR is a viral 
defence mechanism found in bacteria and archaea which, when combined with CRISPR-associated 
protein 9 (Cas9), works in a similar fashion to ZFNs and TALENs, targeting and cutting DNA strands to 
 
allow edits and insertions. This new generation of genome editing technologies allow scientists to modify 
the genome more precisely than past transgenic tools and with fewer off-target effects (Urnov et al. 2010; 
Miller et al. 2011; Hwang et al. 2013; Nuffield Council on Bioethics 2016).   
Plant genome editing is deeply politicised and questions of governance, particularly regulation, remain 
highly contested (Lusser and Davis 2013; Sarewitz 2015a; Kuzma 2016; Kuzma et al. 2016). In Europe, 
plant genome editing taps into existing controversies surrounding the deliberate release of genetically 
modified organisms (GMOs) (Schurman 2004). Since 2007, when it established a New Techniques 
Expert Working Group, the European Commission has examined whether products derived from NPBT 
fall under the scope of Directive 2001/18/EU on Deliberate Release of Genetically Modified Organisms. 
In 2011, a European Commission report recognised the prominent role of European researchers in NPBT 
research and development, concluding NPBT adoption faces two main challenges: regulatory uncertainty 
and the potentially high costs if products derived from NPBT are classified as GMOs (Lusser et al. 2011). 
In anticipation of a decision, GM-critical NGOs1 published a number of joint statements outlining their 
position on NBPT, including an open letter lobbying the Commission to include NPBT in the Directive 
2001/18/EU (Bee-Life et al. 2015). In 2016, in the absence of a European Commission position, the 
Conseil d’État (France) requested a preliminary ruling from the European Court of Justice (Confédération 
paysanne and Others v Premier ministre and Ministre de l’agriculture, de l’agroalimentaire et de la forêt 
Case C-528/16 2018) on whether a variety of herbicide-resistant rapeseed obtained through NPBTs 
should follow the GMO approval process. Finally, in July 2018, the European Court of Justice ruled that 
plant genome editing would fall under the GMO Directive meaning that plants developed through genome 
editing must go through the same regulatory approval pathway as GM plants, which biotechnology 
researchers and developers see as cumbersome and unnecessary. The decision was characterised in the 
journal Nature as a major setback, threatening genome editing research in Europe and halting 
commercialisation (Callaway 2018).  
NGOs in the debate about agricultural biotechnology 
GM-critical NGOs, such as Greenpeace, Friends of the Earth, GM Watch, GM Freeze, in tandem with 
consumer, agricultural and development organisations have had success in Europe and the UK 
galvanising public opinion in opposition to agricultural biotechnology through direct action and political 
pressure (Ansell et al. 2006). However, GM-critical NGOs’ articulation of alternative normative 
commitments to those embedded in dominant agricultural biotechnology policy positions have also 
                                                     
1 Arche Noah, EcoNexus, Friends of the Earth Europe, Friends of the Earth Germany, IG Saatgut, GM Freeze, GM 
Watch, Greenpeace, Global 2000, Réseau Semences Paysennes, Slow Food, Test Biotech, Via Campesina 
 
attracted hostility from various groups (Welsh and Wynne 2013), such as the 107 Nobel Laureates cited 
above. The targeted NGOs are often dismissed as being anti-science (Eden et al. 2006; Welsh and Wynne 
2013), or discredited as ‘partisan publics’ contrasted with an imagined (supportive) ‘pure public’ (Braun 
and Schultz 2010). Although, as Welsh and Wynne (2013) argue, even these imagined ‘pure’, ‘general’ or 
‘silent majority’ publics often share the normative commitments of more vocal NGO activists. In short 
there is a ‘politics of the public’ in terms of how different groups both claim to be the public and also 
imagine (and address) the public, so that “multiple publics … jostle against each other” for legitimacy and 
recognition (Staeheli et al. 2009, p. 634).  
The role of NGOs within controversial science and technology debates is multifaceted, in part due to the 
different ways NGOs define their function and mission, a situation often influenced by their size and 
resources. Considerable efforts have been made to ‘scientise’ agricultural biotechnology governance, 
constraining the policy debate and decision making to matters that can be adjudicated on the basis of 
scientific knowledge, privileging scientific experts, those in control of technical information and 
obscuring value-laden political decisions (Kinchy 2010). To engage in this scientised debate, NGOs 
routinely act as both consumers and producers of science, in the process in-advertently reinforcing the 
scientised terms of adjudication (Eden et al. 2006; Kinchy 2010). However, some NGOs also monitor and 
draw attention to ethical issues associated with emerging science and technology developments through 
campaigns (Smith 2016), and attempt to open up policy debates on agricultural biotechnology to include 
broader non-technical considerations. 
The social and ethical dimensions of agricultural biotechnology  
Underlying the debate about the governance of genome editing is a tension between science and values 
and what counts as ‘science’, (Wickson and Wynne 2012; Sarewitz 2015b; van Mil et al. 2017). 
Historically, the social and ethical dimensions of agricultural biotechnology have been subordinated to 
scientific matters and played a marginal role in the development of governance structures (Hartley 2016a; 
Hartley 2016b). Agricultural biotechnology governance relies heavily on science-based risk assessment in 
regulatory frameworks (Hartley 2016b). Although over 40 countries have included consideration of social 
and ethical dimensions of agricultural biotechnology in their GMO biosafety legislation, there is little 
agreement on the definition of a social or ethical dimension, little research on these dimensions, and a 
reliance on conventional agriculture as a comparator (Catacora-Vargas et al, 2018).  
Since the 1990s, a body of literature has explored the significance of social and ethical issues in emerging 
agricultural biotechnology (Bunton and Peterson 2005; Brunk and Hartley 2012; Federal Ethics 
Committee on Non-Human Biotechnology (ECNH) 2012; Nuffield Council on Bioethics 2012; 
 
Thompson 2015). These issues include the distribution of risks and benefits, the social and economic 
impact on agricultural production systems and communities, transparency, corporate control of the food 
production system, inequalities between the Global north and the Global south, food insecurity, 
biodiversity loss, the role and direction of technological progress, and, ultimately, the desirability of the 
technology (Dowdeswell et al. 2005; Phillips et al. 2010; Hartley 2016a; van Mil et al. 2017). The 
marginalisation of these issues remains a significant tension in agricultural biotechnology governance that 
challenges the legitimacy of governance institutions (Hartley and Millar 2014; Hartley 2016a; Hartley 
2016b). However, in addition to the exclusion of social and ethical considerations, a narrow scientific 
emphasis on molecular biology has also resulted in the marginalisation of other disciplines which have 
resulted in less available funding to explore alternatives such as agroecology (Vanloqueren and Baret 
2009) and led some members of the scientific community to challenge claims of a consensus on the safety 
of GM plants (Hilbeck et al. 2015). 
Methods and research design 
We employ a comparative multi-method approach combining qualitative document, focus group and 
interview analysis. Documents were compiled from environmental, food and farming NGO websites and 
other published materials to identify their positions on the social and ethical issues related to plant 
genome editing. This search identified 64 relevant documents, 61 webpages and 3 joint publications. In 
total 10 GM-engaged NGOs were represented within this document database, however, just over half (31) 
of the webpages were from a single NGO (GM Watch) website. The over-representation of a single NGO 
within this corpus, alongside the limited articulation of the social and ethical issues of primary interest to 
this study meant the collection of focus group and interviews data was deemed essential in order to 
adequately understand the social and ethical issues raised by NGOs engaged with developments in 
genome editing as an emerging agricultural biotechnology.  
We collaborated with GM Freeze, a GM-critical UK-based NGO to identify relevant UK-based NGOs. 
GM Freeze facilitated access to research participants who have traditionally been hard to reach. We 
approached all NGOs active in the UK who had developed a position on plant genome editing. 
Subsequently, one focus group with five participants from different NGOs was held in June 2016. To 
ensure full coverage of the UK-based NGOs identified, semi-structured interviews were held with 
participants unable to attend the focus group in July 2016, to build upon the breadth of knowledge gained 
 
from the focus group interactions2. In total the research involved fourteen UK and EU-based NGOs with 
an interest in genome editing: Beyond GM, Corporate Europe Observatory, Econexus, FARM, Food 
Ethics Council, Friends of the Earth, GeneWatch UK, GM Freeze, GM Watch, Greenpeace, Logos 
Environmental, Soil Association, Sustain, and Permaculture Association (see Table 1.). Due to the small 
nature of several participant NGOs, to remain consistent with the consent provided by participants at the 
start of the project, and in accordance with the ethical procedure approve by the host institution 
(University of Nottingham), all quotes have been anonymised. This group represents a wide range of 
organisations interested in GM developments with considerable differences in size, resources, campaign 
reach and goals. The breadth of NGOs (see Table 1 below) includes small UK based initiatives aiming to 
raise public awareness and broaden the scope of public debates on GM, to mass membership 
organisations with national and international campaigns on environmental and agricultural issues.  
<<Insert Table 1 here>> 
Individuals participated in either the focus group or the interviews but not both. Focus groups are a useful 
tool to generate discussion between participants, give participants greater control over the content than in 
an interview situation, and provide the opportunity for issues to emerge that are unanticipated by the 
research team (Krueger and Casey 2014). An experienced moderator (SH) led the focus group which 
consisted of two two-hour discussion sessions and teased out a range of responses to provide a greater 
understanding of the ethical reasoning, attitudes, opinions and/or perceptions of participants that would be 
less accessible without group interaction (Hennink 2007). Semi-structured interviews with participants 
that did not attend the focus group were conducted via telephone and lasted between 30 and 60 minutes. 
Focus group discussions and all interviews were audio recorded and transcribed. The interviews and the 
focus groups were guided by the same topic areas which aimed to explicitly disentangle scientific from 
social and ethical issues. These areas included a participant’s understanding of; 1] the term New Plant 
Breeding Techniques and genome editing; 2] social and ethical issues; 3] social and ethical issues raised 
by genome editing; 4] the degree to which genome editing introduces social and ethical issues distinct 
from those raised by more established GM techniques; 5] the position of social and ethical issues in 
public and policy discussions regarding GM and genome editing. 
While the use of both focus groups and interviews can be justified for pragmatic reasons (expanding the 
range of participants), careful combination of the methods and iteration between their results during 
                                                     
2 It proved impossible to get all relevant participants together in the UK at the same time. Combining interviews 
with the focus group allowed to us to expand the number of participants.  
 
analysis, can help to identify the structure and context of particular phenomena (Lambert and Loiselle 
2008). For example, the focus group revealed the terminology of plant genome editing to be a key share 
concern by participant NGOs, in a way that could not have emerged in individual interview. While 
acknowledging that the participant NGOs hold a broad range of interests, we found considerable 
agreement between participants around the social and ethical dimensions of plant genome editing across 
the focus group and interview data. In this article, we have focused on these commonalities and compared 
them to the published position of Nuffield. 
Nuffield is the most prominent UK bioethics institution which has intervened within social and ethical 
debates surrounding agricultural biotechnology. Funded since 1994 by the Nuffield Foundation, the 
Medical Research Council and the Wellcome Trust, (Nuffield Council on Bioethics 2018), Nuffield 
operates independently from the UK government although, in practice, is treated by the government as a 
quasi-official body addressing matters of public interest that would be difficult for policymakers to handle 
directly (Jasanoff 2005). Nuffield is primarily constituted of a main council which selects topics of 
interest. Upon determining a topic, the council appoints a working group independent of the council 
(Nuffield Council on Bioethics 2017). The working group is usually made up of senior academics and 
professionals from a range of disciplines and backgrounds with personal expertise in the relevant domain3 
(Nuffield Council on Bioethics 2017).  Subsequently, the group is tasked with gathering evidence and 
drafting the report, with the council responsible for accepting the final report (Nuffield Council on 
Bioethics 2017). It is the final report, once approved, which represents Nuffield’s position.  
Documents including the report Genome editing: An ethical review (Nuffield Council on Bioethics 2016), 
the call for evidence and the evidence submissions, were compiled totalling 46 documents. This was 
reduced to 15 by excluding evidence submissions that had no mention of genome editing in plants for 
commercial agricultural production. The inclusion of the evidence was useful in demarcating the 
Nuffield’s conclusions from the wider pool of evidence submissions. The final report is the principle 
document of reference throughout. This report was authored by a working group that included Andy 
Greenfield (Chair, and Council member, Programme Leader in Developmental Genetics at the Medical 
Research Council’s Harwell Institute, and a member of the Human Fertilisation and Embryology 
Authority), Tony Perry (Department of Biology and Biochemistry, University of Bath), Christine Watson 
                                                     
3 Nuffield does not make clear its criteria for exclusion on the basis of conflicts of interest, however, all 
working parties publish a register of interests and do not represent the organisations to which they are 
affiliated. 
 
(Council member, University of Cambridge), David Lawrence (Council member, Chair of the UK 
Knowledge Transfer Network and Non-Executive Director at Syngenta AG), Charis Thompson (Professor 
of Sociology, London School of Economics and Political Science and Chancellor’s Professor of Gender 
and Women’s Studies, University of California, Berkeley), John Dupré (Professor of Philosophy of 
Science, Exeter University and Director of Egenis, the Centre for the Study of Life Sciences), Richard 
Ashcroft (Professor of Bioethics, School of Law, Queen Mary University of London), Karen Yeung 
(Professor of Law and Director of the Centre for Technology, Ethics and Law in Society (TELOS), 
King’s College London).  
Our comparison between GM-engaged NGO perspectives and the Nuffield text involved two stages. First, 
we conducted a thematic analysis of the data to identify the prominent social and ethical issues regarding 
genome editing discussed by participant NGOs and Nuffield to identify areas of cohesion and disjuncture. 
Second, we employed the concept of framing. As opposed to themes which are descriptive, frame analysis 
examines how discussion of said themes is organised and what elements are emphasised. Frame analysis 
has been used in a variety of contexts relating to salient policy governance issues such as food security 
(Mooney and Hunt 2009; Kirwan and Maye 2013), emerging animal and human health issues such as 
antimicrobial resistance (Morris et al. 2016), and public controversies such as the BSE crisis (Miller 
1999; Washer 2006). Framing is described as the means of structuring experience of the world through 
discursive practices and frame analysis is situated as a means of interrogating this organisation (Goffman 
1974; Entman 1993). More specifically, different groups are positioned as likely to adopt different ways 
of framing issues, which may lead to deeply entrenched differences in perspective on what the problem is 
and how it should be governed. Our analysis aimed to identify these framing differences. We used the 
published text of the Nuffield report as our point of reference due to the symbolic power of that text in 
ethical debates (Jasanoff 2005). Our research interest is in how GM-engaged NGO perspectives compare 
to the ‘received wisdom’ from Nuffield. Further research could investigate in greater detail the processes 
of inclusion and exclusion during the writing of the Nuffield report. However, this is beyond the scope 
and interest of the current article. 
Results  
The results of the analysis are summarised in Table 2 which compares the frames identified in participant 
NGO and Nuffield positions on the social and ethical dimensions of plant genome editing in relation to 
each of four identified themes. We then go on to detail and compare the social and ethical themes and 
frames identified from the participant NGOs and the Nuffield report on genome editing.  
<<Insert Table 2 here>> 
 
Power and control  
For participant NGOs, questions about power and control were a substantive component of their critique 
of genome editing and its ethical consequences, both in their own right, but also as the subtext to wider 
discussions on intensive agriculture. Participants positioned genome editing, not as a neutral technology, 
but as expanding the power agricultural biotechnology corporations hold over industrial agricultural 
systems, and thus farmers and consumers. Participant NGOs argued that genome editing would perpetuate 
the proliferation of intensive systems of production which they understood to be deeply harmful to the 
environment, human health, people’s livelihoods and access to food. One participant argued: 
“This is likely to be a technique that will deliver for largescale monocultures and farming systems 
that undermine farmers’ ability to control what they grow … and big agri-business being in 
control of the seed and genetics.” (Interview 4) 
Central to this theme was the patenting regime which creates a different set of legal requirements for 
farmers using the products of agricultural biotechnology than the royalties regime employed in traditional 
plant breeding. Patenting was key to increased corporate power and control, one participant argued: 
“So it would include corporate control via patenting and the impact of that on farming 
communities, such as being locked into a particular technology, what’s known at the transgenic 
treadmill, where you have to pay more and more [for] seeds and more input; impact on the scale 
of farming, so the trend towards larger rather than smaller farms, monopolies in commercial 
companies …” (Interview 5) 
“The application of genome editing techniques in agriculture and food production is likely to 
extend the penetration of patented products and techniques, … This will increase the power of 
multinational corporations at the expense of those who work the land.” (GM Freeze 2016)  
Participant NGOs highlighted that genome editing does not disrupt this established trend, instead further 
facilitating corporations’ efforts to expand that network of control through enabling new product lines 
which further threatened farmers’ decision making capacity regarding land management.  
In contrast, Nuffield highlights but does not challenge the status quo of intensive agriculture and 
corporate power. Furthermore, these issues are addressed generically in Section 2 of the report Science in 
Context: 
“… the costs associated with … these discoveries can, in practice, only be borne by the major 
corporate firms … with potential consequences for global development, access and distribution, 
and distributive justice” (Nuffield Council on Bioethics 2016, p. 17) 
 
This signposts the NGOs position that the adoption of genome editing benefits major corporate firms over 
farmers and consumers. An explicit discussion of who gains market power from these developments is 
only mentioned once in the plant section, in a footnote, quoting an evidence submission from the British 
Society of Plant Breeders. It notes how the existing situation has “enhanced the global market power of 
breeding companies from outside the EU.” (Nuffield Council on Bioethics 2016, p. 69). Suggesting that a 
major problem with first generation GM technologies and existing regulation is that power has shifted to 
the ‘wrong’ non-EU companies, a consequence that would presumably be resolved by EU companies 
getting in on the action.  
In contrast to NGO participants, Nuffield also notes how genome editing holds promises for 
democratising science. Section 7 Other Uses outlines the potential for CRISPR to open up genetic 
engineering to non-elite discourse and practice, a key promise and risk posed by these technologies. 
Whether this can be replicated in agriculture remains to be seen, but CRISPR may hold promise as a 
means for small and medium size companies to reap the benefits of genome editing. This topic is not 
broached by NGO participants, instead they are focused on challenging the present realities of power 
inequality in agricultural systems which genome editing is positioned as re-enforcing not disrupting.  
Terminology 
NGO participants contested the terminology invoked by the technology developers in the genome editing 
debate. They were highly critical of the use of technical language to discuss the practices of genomic 
manipulation in general and were particularly concerned with the strategic use of language to achieve 
political goals. Terminology of concern included: the metaphor of ‘editing’, the inclusion of genome 
editing in the broader category of NPBT, and the language of ‘precision’ used to describe the practice of 
genome editing. Participants argued that such technical terminology made the debate impenetrable to lay 
audiences, sanitising the controversy through the use of more palatable language, particularly its inclusion 
in the broader category of NPBT. The political motives for using these terms generated significant 
discussion in the focus group. For example: 
“… that with the name it is meant to not only bamboozle or hoodwink the public so they will not 
recognise it, but also the legislators … it’s been a real strategy with the new name to pretend that 
it is not GM” (Focus group P4) 
“Industry basically planned the name to divorce the new GM techniques from what people 
generally see as a bad old GM story.” (Focus group P5) 
 
“Rebranding new genetic engineering as "new breeding techniques" (NBTs) was industry's first 
step in making this new generation of GM appear friendly and kindred to classical plant 
breeding.” (GM Watch 2016) 
Language is used to suggest that appreciable space exists between GM (which remains unpopular) and 
these new technologies, thus implying that genome editing is publicly and politically acceptable to adopt 
outside of existing regulatory frameworks. NGO participants recognised that terminology is important 
and value-laden and challenged what they perceived as deliberate rhetorical choices by GM advocates to 
distance these new technologies from past controversies, whilst reassuring and persuading publics and 
politicians that they are desirable. 
Similarly, the Nuffield report identifies terminology as an important topic. It argues that current 
terminology excludes publics from the framing of risks, expressing their concerns, and the debate more 
generally. Furthermore, Nuffield acknowledge that terminology can shape publics’ perceptions. Specific 
attention is drawn to the problems with the technical and expert driven nature of the discussion around 
genetic engineering: 
“The technical language in which genomic manipulation is discussed by specialists in all 
disciplines ... is frequently impenetrable to common understanding.” (Nuffield Council on 
Bioethics 2016, p. 65) 
By necessity, participant NGOs were often well versed in the terminology and science. Some felt more 
comfortable contesting the science than articulating and critiquing the political commitments of genome 
editing. However, as Nuffield goes on to note, this terminology is used to dismiss the concerns of publics 
who are unable to use the correct technical language, whilst creating space that can be exploited to sow 
uncertainty. Here we see a considerable level of agreement between the Nuffield report and the 
participant NGO’s positions. Yet, in contrast to NGO participants asking ‘why’ questions, Nuffield asks 
the ‘what’ questions. What are the potential issues raised by opaque technical language and by particular 
phrases and words? 
Such divergence is clear in Nuffield’s description of conflicting positions on the semantic use of 
‘precision’ in biotechnology: 
“they [NGOs] point to the mistake of equating ‘precision’ in the ability to manipulate nucleotide 
sequence with precision in the prediction or control of consequences or in terms of gene function. 
Biotechnology researchers typically respond to these claims by alleging that NGOs are 
 
overstating the risks and exploiting uncertainties for political ends.” (Nuffield Council on 
Bioethics 2016, p. 68) 
Questions of why precision has been adopted as the term with which to describe genome editing, and 
whom it is being used by, remain unexplored. Therefore, terminology is recognised as having ethical 
consequences encoding different values, but the interrogation of why these choices have been and are 
being made is outside the boundaries of Nuffield’s analysis. In contrast these questions are central to 
participant NGO interrogation of terminology. 
Consumer choice  
NGO participants repeatedly identified consumers’ right to choose non-GM foods as a salient concern. If 
products produced through genome editing fall outside of existing EU directives on GMOs consumers 
would not be able to select against them. Participants argued strongly that people have a right to 
information and should be enabled to make food choices on their own terms regardless of the nature of 
their objection. For example: 
“… some people would take very strong objection to manipulation of genetic systems in a way 
that cannot happen naturally without interference in the lab. It is a legitimate position for people 
to take and if we’re not careful, that choice will be denied to them.” (Interview 1) 
Consumer choice was entangled with the theme of power and control and participants argued that 
industry proponents of genome editing saw consumer choice as a threat to their power and control so 
sought to limit it. De-regulation was therefore positioned as central to limiting consumer choice by 
seeking to have genome edited plants and food free of the regulatory requirements that constrained GM 
products, in particular labelling. For example: 
“The debate right now is about that the industry is trying to get all of these techniques completely 
deregulated, which means taking away any chance for society to control, to label, to know, to 
have access to information.” (Interview 6) 
“If they [GM advocates] succeed, these GM products won’t carry a GM label and citizens and 
consumers will never know what they are growing in their fields, or feeding their families.” 
(Beyond GM 2016) 
The de-regulation of genome editing is therefore positioned as making them invisible to the public, 
severely limiting consumer choice, whether that choice was made on grounds of scientific, emotional, 
cultural, or religious objections.  
 
Nuffield does not attempt to answer the political question of whether genome editing techniques should 
be covered or not by existing EU directives that require explicit GMO food labelling. Instead the report 
examines what decisions need to be made if genome editing did fall outside of the existing regime of 
GMO regulation. For example,  
“… what information consumers should be able to receive. If it is right that consumers should be 
able to make such a choice on grounds that they themselves choose, labelling may be particularly 
important …” (Nuffield Council on Bioethics 2016, p. 68) 
Nuffield does not attach a value judgement to this decision, in contrast to the stronger position held by 
participant NGOs about the right to make food choices regardless of the criteria on which those choices 
were made. However, the Nuffield report notes how this is potentially not so simple:   
“these ‘edits’ need not leave any tell-tale trace of their origin in the genome, in the sense that 
subsequent genome analysis is able to tell whether they have been introduced intentionally or 
arisen through common or garden random mutation.” (Nuffield Council on Bioethics 2016, p. 
113) 
The inherent capacity of the technology changes the bounds of what can be made visible to regulators and 
consumers creating issues regarding traceability. As a result, the Nuffield report frames the disruption of 
consumer choices as emerging from techno-scientific advance creating inherent difficulties for tracing 
genome edited plants. Thus, technological progress re-opens past regulatory decisions surrounding the 
division of GMO and non-GMO plants. This contrasts with the previously described NGO position 
framing this as an explicit effort to circumvent consumer choices which are implicitly assumed to prefer 
non-GMO foods.  
Problem/solution framings  
NGO participants were sceptical about the problem/solution framings used to justify the need for genome 
editing. This problem of food security is framed as an impending food crisis due to population growth, 
climate change and changing diets, which invites genome editing as a solution. One participant observed: 
“… a guaranteed phrase whenever I read a paper, it always starts off, there are so many billion 
people in the world, by 2020, we need to feed them. If an article starts like that, I can guarantee 
… it’s going to tell me I should be developing GM.” (Focus group P1) 
Participants argued that this crisis framing is not a simple passive declaration of fact about a global reality 
but deeply political and used for political means. Within a highly charged debate an impending crisis 
provides urgency and a claim to the moral high ground. Opposing these techniques is unethical given the 
 
pressing needs of the world. The Laureates’ Letter being a clear example of such a claim. NGO 
participants challenged this problem framing along two lines.   
First, NGO participants contested the nature of the problem. They recognised population growth and 
increased food demands but questioned whether these demands constitute the crisis depicted by pro-GM 
advocates.  
“So you know the whole crisis narrative thing needs to be interrupted, …decide whether there 
really is a problem, and if there is a problem, what the sensible solution is that’s going to keep a 
majority of the stakeholders happy.” (Focus group P5) 
Second, NGOs argued genome editing further exacerbates the problems of intensive systems of 
agricultural production which are in many local and regional contexts the source of food insecurity due to 
the displacement of local people, increased environmental pollution and degradation. Participants argued 
that genome editing offers very little to the majority of subsistence farmers in the global South, therefore 
doing little to resolve food insecurity in these regions: 
“The other [subsistence] food system which is under tremendous threat indeed from the spreading 
industrial food system … using probably only about 30% of the world’s … food production 
resources, delivers food for about 70% of people in the world. And that’s the system which needs 
to be supported.” (Interview 2) 
In contrast, participants situated genome editing in the context of modern intensive agriculture and the 
hegemonic role technology plays in supporting economic growth. They noted the disjuncture between the 
needs of populations and agriculture in the Global South which are largely unaddressed and may be 
exacerbated by genome edited and industrial agriculture. For example: 
“Agriculture is the money-making enterprise. And we were saying the R+D is to make a profit 
from agricultures, it wasn’t about feeding ourselves and food security, it’s about making money.” 
(Focus group P3) 
Nuffield similarly engages with these problem/solution framings, in Section 5 Contending Imaginaries. 
The section begins by painting a significant global challenge comparable to the one critiqued by the NGO 
participants.  
“The Food and Agriculture organisation estimates that we need to increase food production by as 
much as 70% in the next 35 years.” (Nuffield Council on Bioethics 2016, p. 69) 
 
With the gauntlet laid down, genome editing promises potential solutions to alleviate this issue. In 
contrast, NGO participants argue that these problem framings are strategic rhetorical tools which seek to 
justify genome editing whilst seizing the moral high ground from which to discredit opponents. Nuffield 
notes a potential disjuncture between the nature of this challenge and the solutions provided by 
agricultural biotechnology. For example: 
“These [EU economic] interests sit starkly beside another important set of considerations … in 
the discussion of global food security, namely the interests and agency of resource-poor 
communities, which are not natural markets for purely commercial products … Here, too, the 
impact of genome editing is potentially ambiguous and the response to it is a matter of political 
debate.” (Nuffield Council on Bioethics 2016, p. 70) 
Therefore, both Nuffield and participant NGOs recognise that there is a spatial and political dimension to 
positioning genome editing techniques as the supposed solution to global food insecurity.  
Additionally, the Nuffield report catalogues alternative future visions for agriculture. This is motivated by 
the argument that it is important that a particular problem/solution framing does not result in premature 
decisions about which technologies to pursue. Lock-in is a risk to be avoided. NGOs, industry and 
scientist groups are all key proponents of competing framings and solutions to emerging challenges to 
agricultural and food systems and this is reflected in the report. Nuffield interrogates these different 
competing visions by juxtaposing them side by side. For example.   
“Compassion in World Farming argue, for example, that genome editing might aggravate food 
insecurity if genome edited animals are used in industrial systems where animals are fed human 
edible cereals and that contribute to environmental degradation… . The vision promoted by the 
UK’s Royal Society, on the other hand, is one of ‘sustainable intensification’ that harnesses 
biotechnologies to address the multiple constraints of increasing population, water shortages, 
degradation of farmland and climate change.” (Nuffield Council on Bioethics 2016, p. 71) 
Both visions are presented together, but there is no reflection of the relative influence of the Royal 
Society in comparison to Compassion in World Farming or even which vision currently holds dominance 
in research policy. Furthermore, despite a reference to the ‘opportunity cost’ inherent in picking one 
vision over another there is limited reflection on who stands to gain or lose from such choices.  
Discussion  
Our analysis suggests that NGOs’ GM-critical stance on plant genome editing is thematically aligned with 
expert ethical assessment. NGOs and Nuffield both draw attention to a similar cross section of social and 
 
ethical issues as outlined above. However, in contrast to formal ethical assessment which functions to 
scope the boundaries of the conflict, the participant NGOs consistently sought to challenge the status quo, 
attempting to expand the boundaries of discussion to include explicit questions about power and its 
dynamics, particularly with regard to the perceived increase in corporate influence within agricultural 
systems from the adoption of genome editing techniques. Consequently, NGO participants framed their 
engagement through ‘who’ and ‘why’ questions, drawing attention to who is instigating these debates and 
with what intentions.  
Our interview and focus group data reveal a consistent position on plant genome editing which was not 
identifiable through the NGOs’ on-line material, although it was considerably clearer in expert testimony 
to Nuffield and in other calls for evidence. The reasons for this disjoint between on-line material and 
expert testimony is unclear and deserves more investigation because it has important implications for 
NGOs and for public debate on plant genome editing more generally.  
Participant NGOs actively bring key political questions into the foreground by challenging the existing 
order. We argue it is this challenge and associated discussions about alternative innovation paths in 
agricultural biotechnology, which raise the ire of GM proponents by challenging their position as 
beneficiaries of the status quo. The Nobel Laureates attempted to foreground NGOs’ interests and values, 
in this case Greenpeace’s, while dismissing them as being overly emotional and dogmatic. 
Simultaneously, the Laureates minimised their own interests and values by attempting to veil them in the 
language of science and evidence while advocating for a political choice regarding the expansion of 
agricultural biotechnology within agriculture. 
Our results suggest the debate about genome editing has little to do with science and evidence or emotion 
and dogma and more to do with the politics of technology. Within this contestation over the role of 
genome editing in shaping the future of agriculture, all parties are jostling to put forward a set of interests 
and values, but NGOs engaging with GM are attempting to challenge the existing parameters of the 
debate. Specifically, they try to open up a narrow technical debate to broader questions about relations of 
power, research priorities and the future of technology in agriculture. In doing so they seek to politicise 
genome editing. In contrast, Nuffield follows an institutional imperative towards balanced scoping which 
does not explicitly raise or seek to resolve issues of conflict and power.  
Finally, the lack of space in which to meaningfully discuss political questions of agricultural technologies 
raises broader questions about the involvement of NGOs within current processes of public bioethical 
deliberation and public engagement more generally, both in the UK and broader European context. For 
example, in the UK a recent select committee hearing on GM insects failed to gain the involvement of 
 
GM-critical NGO groups (House of Lords Select Committee on Science and Technology 2015). In the 
EU, research has shown how risk decision making for genome editing science contains a range of ethical 
and social concerns which are often closed to public scrutiny within narrow science-based risk regulatory 
processes (Wickson and Wynne 2012; Wynne and Wickson 2012; Hartley and Millar 2014; Hartley 
2016b). Our findings highlight another factor that may be stimulating the observed shift in NGO 
engagement from upstream inputs into the policy and regulatory process to focusing on downstream 
reactions to policy and regulatory outputs (Hartley et al. 2017). Specifically, that when engaging with 
such institutionalised processes of deliberation, NGO critiques are shaped to conform to specific 
institutional framings and logics, in this case Nuffield’s. Given that Nuffield follows an institutional 
imperative towards balanced scoping and does not explicitly raise or seek to resolve issues of power, the 
consequence for NGOs is that their core concerns and questions regarding who wins and why are framed 
out of Nuffield’s report. With such a central part of their critique made absent in the outputs of bodies 
such as Nuffield, the value of continued NGO engagement with such processes are arguably diminished.  
Conclusion 
Our investigation and comparison of current expert ethical and GM-engaged NGO assessments on the 
social and ethical dimensions of agricultural biotechnology through the controversial case of plant 
genome editing has highlighted a large degree of convergence between the different groups. Both 
Nuffield and participant NGOs drew attention to similar set of issues regarding genome editing; the 
problem/solution framings, terminology, impacts on consumer choices and its implications for relations of 
power and control. Whereas participant NGOs put forward arguments for and against particular ethical 
positions, Nuffield’s ethical assessment functioned to scope a discussion whilst drawing short of arguing 
for or against any position.  
This finding mirrors the work of Hedgecoe (2010), who similarly notes, in the context of 
pharmacogenetics, that professional bioethics tends to avoid putting forward arguments for or against 
ethical positions. Furthermore, Hedgecoe goes on to argue that “bioethicists are no longer questioning the 
‘ideologies and technical fantasies of the professional’, but have largely bought into their claims, both 
technical and ethical” (Hedgecoe 2010, p. 180). Such dynamics are likewise apparent in this domain of 
agricultural biotechnology. For example, regarding regulatory traceability and its implications for 
consumer choice, Nuffield discussion is predicated on an acceptance of academic scientists and industry 
claims and future expectations pertaining to the precision and control achievable through genome editing 
techniques, expectations upon which it is assumed that tracing and differentiating genome edits against 
naturally occurring genetic changes will be potentially impossible. In doing so, bioethical assessment is 
 
enrolled in the co-construction and stabilisation of future technological expectations rather than critically 
responding to it (Hedgecoe and Martin 2003). However, more fundamentally, whether we should develop 
technologies that present such a major challenge to the ability of people to make choices over food on 
their own terms remains unaddressed. By ducking such questions bioethics is arguably failing to provide a 
rigorous and critical engagement with genome editing that enables thinking about the kind of futures we 
want to live in (Hedgecoe 2010). 
Yet this is not to argue simplistically that NGOs fulfil such aspirations. As we have shown, NGOs 
articulate a clear, critical position on genome editing based upon critical engagement with relations of 
power and scepticism of scientific and industry claims, and propose alternative food and agricultural 
futures. However, such positionality is not without its limitations. For example, it remains a pertinent 
point that genome editing potentially offers opportunities to ‘democratise genetic engineering’ (Tauxe 
2015). Through articulating a deeply sceptical position towards genome editing technologies, the GM-
critical NGOs are poorly positioned to engage with alternative futures opened up by these technologies, 
such as the potential to disrupt the concentration of power within agricultural biotechnology and 
redistribute benefits amongst a wider range of industry actors. As a result, genome editing may also 
disrupt some of the established NGO critiques surrounding power dynamics in the sector. This is an area 
of ethical reflection that Nuffield is able to open up and GM-critical NGOs have yet to grapple with.  
Alternatively, the NGOs are able to interrogate the context of corporate power and industrial agricultural 
systems with a level of depth that Nuffield may be unable to achieve. In short, NGOs and Nuffield bring 
different value (and values) to the table that are important in shaping their ethical gaze and the ethical 
gaze of others.  
Public involvement, of which NGOs constitute one such public, is an important component of governance 
for emerging techno-science. There is a need to recognise that ethical expertise is not just held by 
professional ethical experts but also by those outside formal institutional contexts. The conclusion is not 
that Nuffield needs to become an issue advocate (Pielke 2007), but to recognise that both Nuffield and 
NGOs engaged with GM, due to their different roles, institutional contexts, and positions in the UK 
polity, both provide valuable ethical insights and offer different resources from which draw ethical 
expertise. Potentially, environmental, food and farming NGOs provide a useful lens to open up debate and 
discussion on the role of emerging technologies, such as genome editing, in agricultural and 
environmental policy-making. This politicisation should be welcomed and engaged with by political 
institutions and public research bodies if they are committed to wider public dialogue and involvement.  
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Tables 
Table 1: Participant NGOs  
 Name Organisational Goal 
1 Beyond GM Public awareness initiative  
2 Corporate Europe 
Observatory 
Not-for-profit corporate lobbying research and campaign group 
3 Econexus Not-for-profit public interest research organisation analysing developments in 
science and technology 
4 FARM Independent campaign organisation that represents sustainable farming within 
the UK 
5 Food Ethics Council Charity advising on food and farming ethics 
6 Friends of the Earth International environmental campaigning group concerned with environmental 
issues 
7 GeneWatch UK Not-for-profit group monitoring developments in genetic technologies 
8 GM Freeze Not-for-profit company campaigning for GM moratorium 
9 GM Watch Organisation providing news and commentary on genetic technology 
developments 
10 Greenpeace International environmental campaigning group concerned with environmental 
issues 
11 Logos Environmental Environmental research consultancy and advocacy organisation for 
environmental NGOs 
12 Soil Association Food and farming charity and organic certification body 
13 Sustain Charity advocating for better food and farming policies 
14 Permaculture Association 
 
Membership association designing and supporting the development of 
permaculture practices 
 
 
 
 
 
 
Table 2: Themes and frames in participant NGO and Nuffield positions on the social and ethical 
dimensions of plant genome editing  
Theme Participant NGO Frames Nuffield Council on Bioethics Frames 
1. Power and 
control 
Genome editing increases corporate 
power through patenting regimes and 
support for intensive agriculture. 
Corporate power and control must be 
challenged. 
Genome editing may either enhance 
corporate power or democratise GM 
 
2. 
Terminology 
Terminology has been designed to 
distance genome editing from GM in 
order to avoid conflict and secure 
public acceptance. Terminology must 
be contested. 
Terminology has social and ethical 
consequences and may be confusing for 
publics. Terminology must be examined. 
3. Consumer 
Choice 
De-regulation of genome edited plants 
and food is a strategic attempt to 
undermine and limit consumer. 
Consumer choice must be defended. 
Outlines consumer choice implications 
as a result of genome editing 
challenging regulatory and tracing 
regimes. 
No judgement on genome editing as a 
GM technology or not 
4. Problem/ 
Solution 
Framings 
Contesting dominant framings. 
Highlights strategic use of crisis 
framings justify GM, to undermine 
regulation and silence NGO opponents 
Balance. Examines different framings. 
Warns against premature lock in. No 
final value judgement on different 
framings 
 
 
